**Question:** The anti-hypertensive agent of choice in pregnancy is

A. Amlodipine
B. Enalapril
C. Methyldopa
D. Nifedipine

**Correct Answer:** C. Methyldopa

**Core Concept:**
Hypertension in pregnancy is a significant health concern that can lead to complications for both the mother and the fetus. It is essential to choose an anti-hypertensive agent that is safe for fetal development and does not interfere with uteroplacental blood flow.

**Why the Correct Answer is Right:**
Methyldopa (Alpha-methyldopa) is a first-line anti-hypertensive agent used in pregnancy due to its safety profile for the fetus. It is a peripheral alpha-2 adrenergic agonist that reduces blood pressure by decreasing peripheral resistance and increasing renal blood flow, which ultimately leads to natriuresis and blood pressure reduction.

**Why Each Wrong Option is Incorrect:**

A. Amlodipine (Calcium channel blocker) is contraindicated in pregnancy due to its potential for fetal toxicity and its effects on uteroplacental blood flow.

B. Enalapril (Angiotensin-converting enzyme inhibitor) has been associated with premature closure of ductus arteriosus and may lead to fetal distress and hypotension.

D. Nifedipine (Calcium channel blocker) shares the same contraindications as Amlodipine regarding fetal safety and uteroplacental blood flow.

**Clinical Pearl:**
Choosing the correct anti-hypertensive agent in pregnancy ensures both maternal and fetal well-being. Methyldopa is the safest option for controlling hypertension in pregnant patients, while avoiding agents like Amlodipine, Enalapril, and Nifedipine due to their potential risks for the fetus.